Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lexington Pharmaceuticals Laboratories is a specialty biotechnology and chemical research company based in Carmel, Indiana, primarily focused on the development of advanced manufacturing processes for high-intensity sweeteners. The company is an affiliate of Heartland Food Products Group and is led by CEO Ted Gelov. Lexington holds numerous patents related to the efficient chlorination of carbohydrates, specifically for the production of sucralose, the active ingredient in Splenda. Its innovations aim to improve yield, reduce environmental waste, and lower production costs in the global sweetener market. Additionally, the company has engaged in natural product discovery, identifying novel compounds such as the phytotoxin mevalocidin.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lexington Pharmaceuticals Laboratories.